Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bernhard J. Eigl
Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy
Clinical Genitourinary Cancer
Oncology
Urology
Incremental Costs of Prostate Cancer Trials: Are Clinical Trials Really a Burden on a Public Payer System?
Canadian Urological Association Journal
Urology
Related publications
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression After First-Line Gemcitabine Plus Cisplatin
Cancer Research and Treatment
Cancer Research
Oncology
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Neoadjuvant Docetaxel, Cisplatin and Fluorouracil Followed by Concurrent Cisplatin Intensity Modulated Radiation Therapy in Treatment of Locally Advanced Nasopharyngeal Carcinoma
Research in Oncology
The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin‐Ineligible Patients With Muscle‐Invasive Localized Urothelial Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
Cerebral Infarction After Cisplatin-Based Chemotherapy.
Postgraduate Medical Journal
Medicine
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma
Journal of Urology
Urology
Nanoparticle Formulations of Cisplatin for Cancer Therapy
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
Nanoscience
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.
Research in Oncology
